Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 50 years of age or older at the time of signing the consent form
- People who are willing to follow all study procedures and sign the required consent form
- People who either have healthy eyes with no known eye conditions, or who have been diagnosed with any stage of Age-Related Macular Degeneration (AMD) and have not yet received treatment for it — eligibility will be confirmed by a central review team
Who may not be able to join:
- People who have already received any medical treatment for AMD (in either eye) — note that nutritional supplements such as AREDS2 formula are still allowed
- People whose eye images cannot be captured at an adequate quality level, as assessed by the central review team
- People with severe vision loss that requires urgent surgery
- People for whom taking retinal images is not safe, due to narrow angles at the front of the eye or sensitivity to light
- People who have a general health condition or eye condition that, in the opinion of the study doctor, would prevent safe participation in the study
- People who are not willing to sign the consent form
- People who are currently enrolled in, or have previously participated in, a clinical trial involving active treatment for AMD
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Amitha Domalpally, MD, PhD, UW School of Medicine and Public Health
Phone: 1-608-262-1334
Australian sites
+61 8 8212 3022
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
AMD Classification by Participant Count; Geographic Location by Participant Count
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.